Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	36.18	101.38	74.44
Graham Fair Price	-9.56	21.08	23.31
PEG	396.79	-1.40	0.28
Price/Book	-4.60	3.19	3.34
Price/Cash Flow	inf	0.00	124.42
Prices/Earnings	24.32	28.22	22.70
Price/Sales	6.48	30.02	28.19
Price/FCF	inf	0.00	124.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	31.42	0.95	0.72
Operating Margin	1.36	0.34	0.34
ROA	-23.80	0.02	0.03
ROE	0.04	0.03	-23.26
ROIC	0.03	0.02	-10.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.00	100.00
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.17	-0.06	-94.78
EPS QOQ	0.81	-0.20	-74.97
FCF QOQ	-0.51	-1.00	-96.60
Revenue QOQ	0.02	-0.07	251.80
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	117.02	171.17	46.27
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.15	0.15	-2.76
Quick Ratio	4.71	3.55	-24.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	25.62	26.45	3.24
Cash	15.94	13.70	-14.06
Capex	-0.05	0.00	inf
Free Cash Flow	0.69	0.00	inf
Revenue	3.04	2.81	-7.50
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	5.15	4.66	-9.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.80	-12.28	-80.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating